Lilly To Pay Utah $24M Over Zyprexa Marketing
Eli Lilly & Co. will pay Utah $24 million in the latest state settlement over the pharmaceutical giant's alleged off-label marketing of the antipsychotic Zyprexa, state officials said Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article